Standard BioTools Inc.

NASDAQ: FLDM · Real-Time Price · USD
3.71
-0.28 (-7.02%)
At close: Apr 06, 2022, 6:00 AM

Standard BioTools Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-59.24M
Depreciation & Amortization
15.57M
Stock-Based Compensation
16.1M
Other Working Capital
-19.93M
Other Non-Cash Items
3.44M
Deferred Income Tax
n/a
Change in Working Capital
-19.93M
Operating Cash Flow
-44.06M
Capital Expenditures
-13.26M
Cash Acquisitions
n/a
Purchase of Investments
n/a
Sales Maturities Of Investments
n/a
Other Investing Acitivies
1.32M
Investing Cash Flow
-11.95M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
15.96M
Financial Cash Flow
15.96M
Net Cash Flow
-40.07M
Free Cash Flow
-57.33M